Tina Larson
President bij RECURSION PHARMACEUTICALS, INC.
Vermogen: 6 M $ op 31-03-2024
Actieve functies van Tina Larson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | Chief Operating Officer | 01-07-2018 | - |
President | 01-10-2019 | - | |
Revagenix , Inc.
Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Chairman | - | - |
Loopbaan van Tina Larson
Eerdere bekende functies van Tina Larson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACHAOGEN | Corporate Officer/Principal | 01-05-2016 | 01-06-2018 |
Roche, Inc. | Corporate Officer/Principal | 01-10-2014 | 01-04-2016 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Opleiding van Tina Larson
Colorado State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
President | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RECURSION PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Roche, Inc. | |
Revagenix , Inc.
Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Health Technology |
- Beurs
- Insiders
- Tina Larson
- Ervaring